DCF — ARNOT-OGDEN MEDICAL CENTER
Enterprise Value: $-246.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-246.9M
Enterprise Value
$-82.6M
PV of Cash Flows
$-164.3M
PV of Terminal Value
$-264.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $287.5M | $-12.9M | -5.0% | $-25.1M | $-22.8M |
| Year 2 | $296.2M | $-10.4M | -4.0% | $-22.9M | $-18.9M |
| Year 3 | $305.0M | $-7.6M | -3.0% | $-20.5M | $-15.4M |
| Year 4 | $314.2M | $-6.3M | -2.0% | $-19.6M | $-13.4M |
| Year 5 | $323.6M | $-5.7M | -2.0% | $-19.4M | $-12.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-246.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$279.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000035821685
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5